• New French Regulatory Agency Announces Transition of Leadership

    • 03 May 2012
    France's newly-formed National Agency for the Safety of Medicines and Health Products (MSNA), which will ostensibly replace Afssaps, announced 5 May that it will retain its existing leader, Dominique Maraninchi, for the new agency. Maraninchi will lead the new agency, established 1 May by decree, after only having been at Afssaps since February 2011. The agency has been under fire for a number of scandals, including the revelations that the agency allowed Servier's diab...
  • AstraZeneca CEO Out as New J&J CEO Takes the Helm

    • 26 April 2012
    Two life sciences giants are experiencing transitions in leadership, as AstraZeneca's Chief Executive Office David Brennan announced he was relinquishing his position effective immediately and incoming Johnson & Johnson (J&J) CEO Alex Gorsky assumes his position at the company on 26 April. Rumors of Brennan's departure have been brewing for some time, but finally came to a head after the firm announced a 19% decrease in first-quarter profits, reports Reuters . T...
  • After String of Quality Issues, J&J CEO Weldon Retires to $143M

    Outgoing Johnson & Johnson (J&J) Chief Executive Officer William Weldon will receive $143 million in retirement pay, according to a regulatory filing released by J&J. The company-and Weldon's reputation-were plagued last year by a large number of quality setbacks that caused the US Food and Drug Administration (FDA) to take notice, including a consent decree between FDA and a Pennsylvania manufacturing plant owned by J&J subsidiary McNeil PPC. Weldon...